Investor Presentaiton
One of the largest in Indian Pharma market with
2 ~ Rs 18 bn sales
Leading positions in key segments - CVS,
GI, Female Healthcare and Respiratory
(participated market segments)
■ 17 brands amongst country's top 300 brands
■ New product launches - a key growth driver
■ Launched >60 new products and line.
extensions in 2010-11
Therapeutic Area-wise Sales Break-up of
Branded Formulations (FY 10-11)
Respiratory, Antiinfective,
Nutraceuticals,
2.4%
10.7%
.10.2%
Dermatology..
3.1%
Biological,
2.9%
Pain
Mgmt...
▪ 24 were first in India
7.3%
■ Dedicated task force of > 4500 people with
therapeutic focus
Others.
10.8%
■ In-licensing arrangements with Bayer
Schering Pharma, Boehringer Ingelheim,
Nycomed, Baxter, Genzyme Inc.
■ Recently entered into JV with Bayer
Healthcare for sales and marketing pharma
products in different therapeutic areas
Note: All market related information sourced from ORG IMS MAT Mar-11
Cardiovascular,
20.0%
Neurological,
3.0%
Diagnostics,
2.0%
Gastro
Intestinal,
17.4%
Female
Healthcare,
10.2%
8View entire presentation